Skip to main content
Skip to content
1 duplicate copy in the archive
Case File
d-23018House Oversight

Report on Stem Cell Policy and Funding under the Obama Administration

Other

The document summarizes publicly known policy changes, funding increases, and a specific clinical trial issue. It contains no new allegations, financial flows, or misconduct involving high‑level offic Obama reversed Bush's limits on federal embryonic stem‑cell funding. NIH stem‑cell funding increased; litigation (Sherley v. Sebelius) resolved in 2012. FDA approved Geron's first hESC‑derived clinic

Date
November 11, 2025
Source
House Oversight
Reference
House Oversight #013482
Pages
2
Persons
1
Integrity
No Hash Available
Loading document viewer...

Ask AI About This Document

0Share
PostReddit
Review This Document

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.

Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.